Journal article · 2024 · Open access
A randomized trial of the impact of symptom monitoring using an electronic patient-reported outcome app on health-related quality of life in postmenopausal breast cancer patients receiving adjuvant endocrine therapy
Breast Cancer, 31(5), 787–797 · Published 26 May 2024 · DOI 10.1007/s12282-024-01592-4
In brief
“A randomized trial of the impact of symptom monitoring using an electronic patient-reported outcome app on health-related quality of life in postmenopausal breast cancer patients receiving adjuvant endocrine therapy” is a 2024 journal article by Hiromi Okuyama and 3 co-authors, published in Breast Cancer. OpenAlex counts 16 citations as of 22 November 2026, which puts it in the top 3% of works published in 2024 by citations. It is open access under a CC BY licence: the full text is free to read at Research Square.
- Citations
- 16
- Most cited in
- 2026 (10)
- Field-weighted impact
- 2.33
- References
- 34
- Authors
- 4
Abstract
Background Electronic patient-reported outcomes (ePRO) monitoring is a useful communication tool for cancer patients and healthcare providers. In this study, we examined the impact of symptom monitoring using an ePRO app on quality of life (QoL) in postmenopausal breast cancer patients receiving adjuvant endocrine therapy. Methods The free app “Welby My Carte ONC” was used in the study. Patients with breast cancer starting adjuvant endocrine therapy were randomly assigned in a 1:1 ratio to ePRO monitoring (ONC) and control groups. The ONC group reported five symptoms extracted from the Patient-Reported Outcome-Common Terminology Criteria for Adverse Events (PRO-CTCAE) (insomnia, joint pain, headache, anxiety, and hot flashes) weekly for 3 months through the app. Reported symptoms were shared with medical personnel. When serious symptoms were reported, these personnel ascertained the patient's health status and provided advice over the phone. The primary endpoint was QoL measured by the Functional Assessment of Cancer Therapy-Breast (FACT-B) at 3 months from enrollment. Differences between groups were tested using analysis of covariance. Results The study included 125 subjects with mean age of 64 years in the ONC group (n = 61) and 63 years in the control group (n = 64). In the ONC group, the response rate to PRO-CTCAE was about 70% or higher until week 10. The item missing rate was 0. The ONC group reported more symptoms related to joint pain and insomnia. The difference in FACT-B total score between the groups was − 1.55 (95% confidence interval: -5.91, 2.81), indicating no significant difference. Conclusions Symptom monitoring using ePRO early after initiation of adjuvant endocrine therapy after surgery did not improve QoL of breast cancer patients.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Okuyama, H., Takada, F., Taira, N., & Nakamura, S. (2024). A randomized trial of the impact of symptom monitoring using an electronic patient-reported outcome app on health-related quality of life in postmenopausal breast cancer patients receiving adjuvant endocrine therapy. Breast Cancer, 31(5), 787–797. https://doi.org/10.1007/s12282-024-01592-4
MLA 9
Okuyama, Hiromi, et al. “A randomized trial of the impact of symptom monitoring using an electronic patient-reported outcome app on health-related quality of life in postmenopausal breast cancer patients receiving adjuvant endocrine therapy.” Breast Cancer, vol. 31, no. 5, 2024, pp. 787–797. https://doi.org/10.1007/s12282-024-01592-4.
Chicago
Okuyama, Hiromi, Fuka Takada, Naruto Taira, and Seigo Nakamura. 2024. “A randomized trial of the impact of symptom monitoring using an electronic patient-reported outcome app on health-related quality of life in postmenopausal breast cancer patients receiving adjuvant endocrine therapy.” Breast Cancer 31 (5): 787–797. https://doi.org/10.1007/s12282-024-01592-4.
Harvard
Okuyama, H. et al. (2024) ‘A randomized trial of the impact of symptom monitoring using an electronic patient-reported outcome app on health-related quality of life in postmenopausal breast cancer patients receiving adjuvant endocrine therapy’, Breast Cancer, 31(5), pp. 787–797. doi:10.1007/s12282-024-01592-4.
IEEE
H. Okuyama, F. Takada, N. Taira, and S. Nakamura, “A randomized trial of the impact of symptom monitoring using an electronic patient-reported outcome app on health-related quality of life in postmenopausal breast cancer patients receiving adjuvant endocrine therapy,” Breast Cancer, vol. 31, no. 5, pp. 787–797, 2024, doi: 10.1007/s12282-024-01592-4.
BibTeX
@article{okuyama2024randomized,
title = {{A randomized trial of the impact of symptom monitoring using an electronic patient-reported outcome app on health-related quality of life in postmenopausal breast cancer patients receiving adjuvant endocrine therapy}},
author = {Okuyama, Hiromi and Takada, Fuka and Taira, Naruto and Nakamura, Seigo},
journal = {Breast Cancer},
year = {2024},
volume = {31},
number = {5},
pages = {787--797},
doi = {10.1007/s12282-024-01592-4},
url = {https://doi.org/10.1007/s12282-024-01592-4}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Health Sciences › Medicine › Oncology › Cancer survivorship and care
- electronic patient-reported outcomes
- symptom monitoring
- health-related quality of life
- postmenopausal breast cancer
- adjuvant endocrine therapy
- PRO-CTCAE
- insomnia
- joint pain
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Okuyama, H., Takada, F., Taira, N., & Nakamura, S. (2024). A randomized trial of the impact of symptom monitoring using an electronic patient-reported outcome app on health-related quality of life in postmenopausal breast cancer patients receiving adjuvant endocrine therapy. Breast Cancer, 31(5), 787–797. https://doi.org/10.1007/s12282-024-01592-4
How many times has this paper been cited?
16 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Research Square: sign in and open the PDF from this page.
Who wrote this paper?
Hiromi Okuyama, Fuka Takada, Naruto Taira, Seigo Nakamura.
What is the DOI of this paper?
10.1007/s12282-024-01592-4, permanently at https://doi.org/10.1007/s12282-024-01592-4. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.